Erenumab effectively induces Medication Overuse Headache remission in chronic migraine patients. Monthly 140 mg injections show significant...

Highlights: Erenumab 140 mg achieved 69.1% Medication Overuse Headache remission at 6 months Erenumab 70 mg also

WEDNESDAY, Sept. 18, 2024 -- Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH)...

medlinkPomalidomide/medlink, a cancer medication, has been revealed in a clinical trial to be safe and efficacious in treating hereditary...

medlinkPomalidomide/medlink, a cancer medication, has been revealed in a clinical trial to be safe and efficacious in treating hereditary...

Janice Maclean also failed to dispense medication to a number of patients in a timely manner on two occasions.

Janice Maclean also failed to dispense medication to a number of patients in a timely manner on two occasions.

TARRYTOWN, N.Y. and PARIS, Sept. 11, 2024. Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a Dupixent (dupilumab) confirmatory Phase 3...

TARRYTOWN, N.Y. and PARIS, Sept. 11, 2024. Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a Dupixent (dupilumab) confirmatory Phase 3...

Artificial intelligence (AI) comes with risks as well as benefits, but must have specialist doctor oversight when treating patients, says the Royal...